Trevena (TRVN) : $5.10 +27.82%

52w: 3.35 - 25.75

Shares Outstanding : 852.930

Total Cash (mrq) 16.37M

Total Cash Per Share (mrq) 19.19

https://d1io3yog0oux5.cloudfront.net/_4bae5ba5811c335a3586683c60a2e0cf/trevena/db/780/8011/pdf/Trevena+Corp+Presentation+AUGUST+2024+vFINAL.pdf

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

https://www.trevena.com/

Time for a strong rebound?

Sep 09, 2024 5.15

Jul 15, 2024 6.75

Jun 17, 2024 10.75

Sep 25, 2023 25.75

https://x.com/CoachNickMoney/status/1833430024118022310/photo/1